Published in Ann R Coll Surg Engl on September 01, 1998
Primary jejunoileal neoplasmas: a review of 60 cases. World J Gastroenterol (2003) 0.81
Laparoscopic cholecystectomy: potential for missed pathology. Ann R Coll Surg Engl (1994) 3.03
Malignant tumors of the small intestine. Cancer (1983) 1.56
Adenocarcinoma of the small intestine. Am J Surg (1984) 1.51
Primary neoplasms of the small intestine. Am J Surg (1986) 1.45
Malignant tumors of the small intestine. Surg Clin North Am (1986) 1.09
Primary small bowel malignant tumors. Unrecognized until emergent laparotomy. Am Surg (1989) 1.05
Small bowel tumours: a diagnostic challenge. J R Coll Surg Edinb (1994) 1.04
Primary tumours of the small intestine. Ann R Coll Surg Engl (1974) 1.03
Primary tumors of the small bowel. Am J Surg (1975) 1.02
Primary malignant tumors of the small intestine: analysis of 40 Japanese patients. J Surg Oncol (1992) 0.89
Primary malignant tumors of the small intestine. A twenty-two year experience with thirty patients. Am J Surg (1978) 0.85
Gastro-intestinal bleeding from small bowel leiomyomata. J R Coll Surg Edinb (1987) 0.84
A new pattern of histologic predominance and distribution of malignant diseases of the small intestine. Surg Gynecol Obstet (1987) 0.80
Primary gastric lymphoma: incidence and role of surgery. Ir Med J (1989) 0.80
Laparoscopic cholecystectomy: potential for missed pathology. Ann R Coll Surg Engl (1994) 3.03
Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res (2007) 1.97
Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer (2002) 1.79
MicroRNAs as Novel Biomarkers for Breast Cancer. J Oncol (2009) 1.72
Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Clin Cancer Res (2001) 1.69
Minimally invasive parathyroidectomy with operative ultrasound localization of the adenoma. Surg Endosc (2004) 1.58
Prognostic significance of oestrogen receptor beta in breast cancer. Br J Surg (2000) 1.58
Interns and their smartphones: use for clinical practice. Postgrad Med J (2013) 1.57
Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res (1999) 1.55
Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat (2010) 1.54
Authorship trends in the surgical literature. Br J Surg (2010) 1.52
Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer (1998) 1.51
Timing of pre-emptive tenoxicam is important for postoperative analgesia. Can J Anaesth (2001) 1.48
Role of microRNAs in obesity and the metabolic syndrome. Obes Rev (2009) 1.47
Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res (1999) 1.41
A pilot project of European Working Time Directive compliant rosters in a university teaching hospital. Surgeon (2008) 1.40
Breast screening--a surgeon's perspective. Ir Med J (1993) 1.40
Testicular torsion following orchidopexy for undescended testis. Br J Surg (1990) 1.39
Pregnancy associated breast cancer. Ir Med J (2010) 1.39
Preparing new doctors for clinical practice: an evaluation of pre-internship training. Ir Med J (2013) 1.38
Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res (1998) 1.29
Endoscopic management of common duct stones with laparoscopic cholecystectomy. Ir J Med Sci (1991) 1.27
Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab (2011) 1.22
Postoperative fluid therapy--put not thy faith in dextrose saline: discussion paper. J R Soc Med (1991) 1.17
Optimal education techniques for basic surgical trainees: lessons from education theory. J R Coll Surg Edinb (1999) 1.13
Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol (1999) 1.13
Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg (2005) 1.12
Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol (2001) 1.11
Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer (2000) 1.10
Magnetic-resonance imaging for breast cancer. Lancet (1998) 1.08
Prognostic implications of p53 and bcl-2 expression in 108 women with stage two breast cancer. Ir J Med Sci (2001) 1.07
Quality of life after immediate breast reconstruction and skin-sparing mastectomy - a comparison with patients undergoing breast conserving surgery. Eur J Surg Oncol (2011) 1.07
Breast reconstruction in the United Kingdom and Ireland. Br J Surg (2002) 1.05
MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg Oncol (2011) 1.05
Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort. Breast Cancer Res Treat (2009) 1.03
Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study. Urology (2004) 1.03
Systemic mirnas as potential biomarkers for malignancy. Int J Cancer (2012) 1.02
Circulating miR-34a levels are reduced in colorectal cancer. J Surg Oncol (2012) 1.00
Growth arrest-specific gene 6 expression in human breast cancer. Br J Cancer (2008) 1.00
Factors influencing medical students and junior doctors in choosing a career in surgery. Surgeon (2010) 0.99
MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol (2011) 0.98
Surgery in the treatment of varicose veins. Ir Med J (1989) 0.98
An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma. Br J Cancer (1995) 0.98
Meralgia paraesthetica following laparoscopic inguinal hernia repair. An anatomical analysis. Surg Endosc (1995) 0.98
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries. Br J Surg (2010) 0.96
Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets? Hum Gene Ther (2010) 0.95
Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res (1998) 0.95
Gilmore's groin repair in athletes. J Orthop Sports Phys Ther (2000) 0.94
CA15-3: its relationship to clinical stage and progression to metastatic disease in breast cancer. Br J Surg (1989) 0.94
Localised amyloid tumour of breast--a case report. Ir J Med Sci (1984) 0.93
A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer. Eur J Surg Oncol (2007) 0.93
Squamous cell carcinoma of the colon in an asbestos worker. Eur J Surg Oncol (1999) 0.92
Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesions. Ann Surg (1999) 0.92
Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast. Int J Oncol (1999) 0.91
Unilateral breast masses in men over 40: a diagnostic dilemma. Am J Surg (1995) 0.91
Multiple sclerosis: assessment of colonic and anorectal function in the presence of faecal incontinence. Int J Colorectal Dis (1993) 0.90
Radial scars/complex sclerosing lesions and malignancy in a screening programme: incidence and histological features revisited. Histopathology (2007) 0.90
Mammographic assessment of the symptomatic nonsuspicious breast. Am J Surg (1997) 0.90
Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol (1998) 0.90
Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery? Br J Cancer (1998) 0.89
Genetic changes associated with telomerase activity in breast cancer. Int J Cancer (1999) 0.89
Are elevated levels of the tumour marker CA19-9 of any clinical significance?--an evaluation. Ir J Med Sci (1999) 0.88
CA15-3: a reliable indicator of metastatic bone disease in breast cancer patients. Ann R Coll Surg Engl (1992) 0.86
A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma. Eur J Cancer (1992) 0.85
Relationship between CCL5 and transforming growth factor-β1 (TGFβ1) in breast cancer. Eur J Cancer (2011) 0.85
17q12-21 - the pursuit of targeted therapy in breast cancer. Cancer Treat Rev (2010) 0.85
Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells. Int J Oncol (1999) 0.84
The role of sentinel lymph node biopsy in ductal carcinoma in situ. Eur J Surg Oncol (2005) 0.83
Aspiration cytology and its relevance to the diagnosis of solid tumors of the breast. Surg Gynecol Obstet (1987) 0.83
Urinary cytology in the detection of bladder carcinoma. Ir J Med Sci (1991) 0.83
The h index and the identification of global benchmarks for breast cancer research output. Breast Cancer Res Treat (2011) 0.82
The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study. Eur J Surg Oncol (2001) 0.82
Conservative management of a desmoid tumour in pregnancy. J Obstet Gynaecol (2004) 0.82
The routine use of post-operative drains in thyroid surgery: an outdated concept. Ir Med J (2010) 0.82
Estrogen receptor beta and breast cancer. Eur J Surg Oncol (2004) 0.82
Isolated resectable pancreatic metastasis 10 years post gastrectomy. Ir J Med Sci (2001) 0.81
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Br J Cancer (2011) 0.81
The predictive of tumour markers CA 15-3, TPS and CEA in breast cancer recurrence. Breast (2000) 0.81
Optimum duration of surgical scrub-time. Br J Surg (1991) 0.81
Anorectal functional deficit in the Brown Bowel syndrome. Ir J Med Sci (1994) 0.81
Audit of clinical and histological prognostic factors in primary invasive squamous cell carcinoma of the skin: assessment in a minimum 5 year follow-up study after conventional excisional surgery. Br J Plast Surg (2002) 0.81
Molecular profiling techniques and bioinformatics in cancer research. Eur J Surg Oncol (2006) 0.81
A case of bilateral breast cancer with Peutz-Jeghers syndrome. Eur J Surg Oncol (2005) 0.81
Changing practices in the surgical management of hyperparathyroidism - a 10-year review. Surgeon (2011) 0.80
Primary gastric lymphoma: incidence and role of surgery. Ir Med J (1989) 0.80
Cyclical ischaemic preconditioning modulates the adaptive immune response in human limb ischaemia-reperfusion injury. Br J Surg (2009) 0.80
Argon-enhanced cutting and coagulation confers advantages over conventional electrocautery for mastectomy. Eur J Surg Oncol (1996) 0.80
Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified? J Clin Pathol (2009) 0.80
Direct activation of oestrogen receptor-alpha by interleukin-6 in primary cultures of breast cancer epithelial cells. Br J Cancer (2000) 0.80
Successful use of 'Epidrum' loss-of-resistance device for thoracic paravertebral blockade in patients undergoing breast cancer surgery: a case series. Eur J Anaesthesiol (2014) 0.79
Graves' ophthalmopathy: the case for thyroid surgery. Surgeon (2009) 0.79
The parotid gland: an unusual site of metastasis from carcinoma of breast. Ir J Med Sci (2001) 0.79
Roles for the calcium sensing receptor in primary and metastatic cancer. Eur J Surg Oncol (2006) 0.79
Multicentricity and recurrence of breast cancer. Lancet (1997) 0.79
Comparison of three methods for measuring cigarette smoking in patients with vascular disease. Cardiovasc Surg (1994) 0.79
The role of aspiration cytologic examination in the diagnosis of carcinoma of the breast. Surg Gynecol Obstet (1991) 0.78
A prospective evaluation of CA15-3 in stage I carcinoma of the breast. J Am Coll Surg (1995) 0.78
Water-clear cell adenoma: A rare form of hyperparathyroidism. Int J Surg Case Rep (2013) 0.78